Recent studies suggest that baclofen, an agonist of B type receptors of the inhibitory neurotransmitter, -aminobutyric acid (GABA), employed for more than 20 years in the treatment of muscle rigidity, also helps patients affected by alcohol dependence to achieve and maintain abstinence from alcohol. Despite the high number of patients affected by alcohol dependence and by other mental disorders, few pharmacological studies have been conducted in this special population. This study describes the effectiveness and safety of one year baclofen treatment in a patient affected by alcohol dependence and schizophrenia.
Baclofen suppresses alcohol intake and craving for alcohol in a schizophrenic alcohol-dependent patient. A case report
AGABIO, ROBERTA
Primo
Writing – Original Draft Preparation
;CARPINIELLO, BERNARDOPenultimo
Writing – Original Draft Preparation
;
2007-01-01
Abstract
Recent studies suggest that baclofen, an agonist of B type receptors of the inhibitory neurotransmitter, -aminobutyric acid (GABA), employed for more than 20 years in the treatment of muscle rigidity, also helps patients affected by alcohol dependence to achieve and maintain abstinence from alcohol. Despite the high number of patients affected by alcohol dependence and by other mental disorders, few pharmacological studies have been conducted in this special population. This study describes the effectiveness and safety of one year baclofen treatment in a patient affected by alcohol dependence and schizophrenia.
| File | Dimensione | Formato | |
|---|---|---|---|
|
Agabio et al., 2007.pdf
Solo gestori archivio
Descrizione: Articolo principale
Tipologia:
versione editoriale (VoR)
Dimensione
76.05 kB
Formato
Adobe PDF
|
76.05 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I metadati presenti in IRIS UNICA sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono protetti da diritto d'autore, salvo diversa indicazione.
